Pancreatic Cancer Research

ResearcherAbramson Cancer CenterActive in the last 2 years

Ravi K. Amaravadi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5768-2474; OpenAlex author ID A5009482043; NIH RePORTER profile ID 8183362. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
1
Labs led
0
Collaborators
35
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper, 1 grant

Papers 4

  1. Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated m… Co-author DOI 10.1136/jitc-2025-012864↗
  2. Pumping Iron: Ferritinophagy Promotes Survival and Therapy Resistance in Pancreatic Cancer. First author DOI 10.1158/2159-8290.cd-22-0734↗
  3. A Randomized Phase II Preoperative Study of Autophagy Inhibition with High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer Patients. Co-author DOI 10.1158/1078-0432.ccr-19-4042↗
  4. Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer: A Phase 2 Randomized Clinical Trial. Co-author DOI 10.1001/jamaoncol.2019.0684↗

Grants 1

  1. Cancer Therapeutics Program P30CA016520↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kim A Reiss Binder · 1 shared grant, 2026 · strength 0.77
  2. Caryn Lerman · 1 shared grant, 2026 · strength 0.77
  3. Naomi B Haas · 1 shared grant, 2026 · strength 0.77
  4. Tapan Ganguly · 1 shared grant, 2026 · strength 0.77
  5. Vaibhav Jain · 1 shared paper, 2022 · strength 0.33
  6. Mark H. O’Hara · 2 shared papers, 2019–2026 · strength 0.30
  7. Zev A. Wainberg · 1 shared paper, 2026 · strength 0.22
  8. Andrew H. Ko · 1 shared paper, 2026 · strength 0.22
  9. William Arthur Hoos · 1 shared paper, 2026 · strength 0.22
  10. Robert A. Wolff · 1 shared paper, 2026 · strength 0.22
  11. Eileen Mary O'Reilly · 1 shared paper, 2026 · strength 0.22
  12. Lacey Padrón · 1 shared paper, 2026 · strength 0.22
  13. Robert H. Vonderheide · 1 shared paper, 2026 · strength 0.22
  14. Alec C. Kimmelman · 1 shared paper, 2026 · strength 0.22
  15. George Albert Fisher · 1 shared paper, 2026 · strength 0.22
  16. Jennifer Lee Miller-Ocuin · 1 shared paper, 2020 · strength 0.09
  17. Melissa Ellen Hogg · 1 shared paper, 2020 · strength 0.09
  18. Pranav Murthy · 1 shared paper, 2020 · strength 0.09
  19. Amer H. Zureikat · 1 shared paper, 2020 · strength 0.09
  20. Allan Tsung · 1 shared paper, 2020 · strength 0.09
  21. Herbert J. Zeh · 1 shared paper, 2020 · strength 0.09
  22. David L. Bartlett · 1 shared paper, 2020 · strength 0.09
  23. Nathan Bahary · 1 shared paper, 2020 · strength 0.09
  24. Daolin Tang · 1 shared paper, 2020 · strength 0.09
  25. Brian A. Boone · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.